Larson Financial Group’s Verona Pharma VRNA Stock Holding History

Larson Financial Group’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1	Closed	-$107	–	3675
2025 Q3	$107	Buy	+1	New	+$104	﹤0.01%	3321
2024 Q1	–	Sell	-25	Closed	-$497	–	1902
2023 Q4	$497	Hold	25	–	–	﹤0.01%	1576
2023 Q3	$408	Hold	25	–	–	﹤0.01%	1595
2023 Q2	$529	Hold	25	–	–	﹤0.01%	1433
2023 Q1	$502	Hold	25	–	–	﹤0.01%	1412
2022 Q4	$653	Hold	25	–	–	﹤0.01%	1347
2022 Q3	$0	Hold	25	–	–	﹤0.01%	1408
2022 Q2	$0	Buy	+25	New	+$107	﹤0.01%	1304

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Larson Financial Group's VRNA Position: Q4 2025 in Review

Larson Financial Group sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 1 share — an estimated $107 sold.

Larson Financial Group first reported a position in VRNA in Q2 2022 and held it in 8 quarters. The position peaked at $653 in Q4 2022. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Larson Financial Group reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Larson Financial Group sold 1 Verona Pharma share in Q4 2025, an estimated $107.
Larson Financial Group first reported a position in Verona Pharma in Q2 2022 and held it in 8 quarters.
Larson Financial Group's Verona Pharma position peaked at $653 in Q4 2022.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Larson Financial Group's 13F filing for Q4 2025, filed 6 Feb 2026.